Reviva Pharmaceuticals Holdings, Inc
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage pharmaceutical company based in Cupertino, California, focused on discovering and developing novel therapies for central nervous system, respiratory, and metabolic diseases. The company aims to address significant unmet medical needs and improve patient outcomes through the development of safer and more effective treatment options.
Reviva's lead drug candidate, brilaroxazine (RP5063), is currently in clinical development for various neuropsychiatric indications, including schizophrenia, bipolar disorder, and attention deficit hyperactivity disorder (ADHD). The company leverages chemical genomics-driven technology to create innovative therapeutics that can make a meaningful impact on patients' lives.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.